AstraZeneca Staff Detained in China Amid Data and Drug Import Investigations

Recently, it was reported that several employees of pharmaceutical company AstraZeneca have been detained in China. This occurred as part of a large-scale investigation concerning both imported medical goods and compliance with data related to the quality and safety of medications. These developments raise questions about the stringent measures being taken by Chinese authorities to regulate the pharmaceutical industry.

Continue reading